// App-Quantinova.ai

975 : Monitoring Measurable Residual Disease Using Peripheral Blood in Acute Lymphoblastic Leukemia: Results of a Prospective, Observational Study

Researchers

Presenter

  • Lori Muffly

Principal Investigators

  • Connie Chen

  • Ilana Yurkiewicz

  • Eric Kuo

  • Sarah Burnash

  • Jay Y. Spiegel

  • Kelly Chyan

  • Sally Arai

  • Matthew J. Frank

  • Laura J. Johnston

  • Robert Lowsky

  • Everett H Meyer

  • Robert S. Negrin

  • Andrew R. Rezvani

  • Surbhi Sidana

  • Parveen Shiraz

  • Judith A Shizuru

  • Wen-Kai Weng

  • Michaela Liedtke

  • Hyma T. Vempaty

  • David B. Miklos

Medical Centers

  • Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA

  • Quantitative Sciences Unit/Medicine, Stanford University, Palo Alto, CA

  • Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA

  • Division of Rheumatology, Stanford University Medical Center, Palo Alto, CA

  • Department of Medicine, Stanford University, Stanford, CA

  • Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA

  • Stanford Univeresity Medical Center, Stanford, CA

  • Division of Hematology, Stanford University, Stanford, CA

  • Kaiser Permanente, Santa Clara, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Hematocrit

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Adaptive

  • Observational

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved